Dr. Sherif F. Yacoub
Claim this profileEphrata Cancer Center
Studies Prostate Adenocarcinoma
Studies Small Cell Carcinoma
6 reported clinical trials
30 drugs studied
Area of expertise
1Prostate Adenocarcinoma
2Small Cell Carcinoma
Stage IV
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Sherif F. Yacoub is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
More about Sherif F. Yacoub
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Sherif F. Yacoub has experience with
- Radiation Therapy
- Degarelix
- Bicalutamide
- Triptorelin
- Flutamide
- Histrelin
Breakdown of trials Sherif F. Yacoub has run
Prostate Adenocarcinoma
Small Cell Carcinoma
Small Cell Lung Cancer
Prostate Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sherif F. Yacoub specialize in?
Sherif F. Yacoub focuses on Prostate Adenocarcinoma and Small Cell Carcinoma. In particular, much of their work with Prostate Adenocarcinoma has involved treating patients, or patients who are undergoing treatment.
Is Sherif F. Yacoub currently recruiting for clinical trials?
Yes, Sherif F. Yacoub is currently recruiting for 6 clinical trials in Ephrata Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Sherif F. Yacoub has studied deeply?
Yes, Sherif F. Yacoub has studied treatments such as Radiation Therapy, Degarelix, Bicalutamide.
What is the best way to schedule an appointment with Sherif F. Yacoub?
Apply for one of the trials that Sherif F. Yacoub is conducting.
What is the office address of Sherif F. Yacoub?
The office of Sherif F. Yacoub is located at: Ephrata Cancer Center, Ephrata, Pennsylvania 17522 United States. This is the address for their practice at the Ephrata Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.